Forward P/S Multiple: Apyx Medical Corp (APYX)

Apyx Medical Corporation - graphic logo of issuer APYX

The forward price-to-sales valuation trend highlights a steady cash inflow from the sale of disposable components for plasma systems. However, fierce competition for surgeons' attention and pressure from laser manufacturers create significant challenges. The 2.00 level is recording new values amid concerns over FDA claims and potential litigation, which are reducing the overall profitability of Apyx Medical.

Apyx Medical Corporation - APYX Market Cap to Projected Revenue (period 07/04/2022 - 11/13/2026)

Summary analytical data breakdowns for apyxmedical.com (APYX)

- market price and analyst price targets:
Price Chart Apyx Medical Corporation|APYX - Consensus Target
- company stock exchange capitalization indicators:
Market Capitalization APYX|APYX - Total Enterprise Value
- issuer book value statistics:
Book Value per Share Apyx Medical|APYX - Accounting Capitalization|Market Capitalization to Book Value Ratio apyxmedical.com|APYX - Company Total Asset Base
- debt and liquidity data:
Total Debt to Capital Apyx Medical|APYX - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Apyx Medical Corporation|APYX - Company Aggregate Debts|Debt to Book Capitalization Ratio APYX|APYX - Company Long-Term Debt|Company Current Liabilities Apyx Medical|Quick Ratio apyxmedical.com
- financial results and valuation multiples details:
APYX - Company Net Income|Expected Profit Apyx Medical|APYX - Market Cap to Net Income Ratio|Projected Price to Earnings Apyx Medical Corporation|APYX - PEG Multiple|EV/EBITDA Multiple APYX|APYX - Operating income before deduction of amortization|Earnings per share for the last twelve months Apyx Medical|APYX - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months apyxmedical.com|APYX - Net earnings per share growth this year|Earnings growth forecast for next year Apyx Medical
- sales and revenue indicators:
APYX - Company Total Revenue|Company Projected Revenue Apyx Medical Corporation|APYX - Market Cap to Revenue Ratio|Forward Price-to-Revenue Multiple APYX
Fundamental company analysis:APYX (Bovie Medical)
Product sample of apyxmedical.com

The forward P/S reflects the market value of the business relative to expected sales volume, allowing for an assessment of the premium paid for future growth rates. By analyzing the projected market cap-to-revenue ratio, an investor can gauge the market's reaction to financial reports, which is critical for Apyx Medical (APYX), as its valuation relies on the commercial success and demand for Renuvion high-precision helium plasma systems.

Who Apyx Medical competes with

Price-to-Projected Revenue Ratio Dexcom DXCM|PEN - Forward Price-to-Revenue Multiple|Novanta Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Haemonetics Company|INSP: Forward P/S Multiple|Market Cap to Projected Revenue PRCT|CNMD (CONMED) - Forward P/S Multiple|Pulse Biosciences Inc (PLSE) - Market Cap to Expected Sales Ratio|Forward P/S Multiple INMD|Forward Price-to-Revenue Multiple Picard Group PMI|Forward P/S Multiple SRDX (Surmodics, Inc.)|Forward P/S Multiple senseonics.com SENS|NPCE - Price-to-Projected Revenue Ratio|TCMD: Price-to-Projected Revenue Ratio|SNWV (SANUWAVE Health, Inc.) - Forward Price-to-Revenue Multiple|Outset Medical Corp - Forward Price to Sales|ELMD (SmartVest) - Forward P/S Multiple|Market Cap to Future Revenue Ratio lensar.com LNSR|Price-to-Projected Revenue Ratio AVITA Medical (RCEL)|profoundmedical.com (PROF) - Projected Price to Revenue|Baird Medical - Forward Price-to-Revenue Multiple|Forward P/S Multiple EDAP TMS SA EDAP|IceCure Medical, Ltd. - Forward P/S Multiple|Market Cap to Expected Sales Ratio Pulmonx Corporation LUNG|telabio.com (TELA) - Price-to-Projected Revenue Ratio|Future Price to Revenue CTSO (CytoSorbents Corporation)|Price-to-Projected Revenue Ratio Sensus Healthcare Corp|Forward Price-to-Revenue Multiple Zynex Corp (ZYXI)|Forward P/S Multiple ECOR|RBOT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Inspira Technologies IINN|ICU: Market Cap to Projected Revenue|IRIX: Forward Price-to-Revenue Multiple|Intelligent Bio Solutions - Price to Expected Revenue Ratio|XAIR: Forward P/S Multiple|profusa.com (PFSA) - Forward P/S Multiple|Price-to-Projected Revenue Ratio STRATA Skin Sciences Inc.|glucotrack.com - Future Price to Revenue|Forward Price-to-Revenue Multiple NAOV (NanoVibronix)|VERO - Market Cap to Future Revenue Ratio|Nuwellis, Inc. - Forward Price-to-Revenue Multiple|AEMD: Market Cap to Projected Revenue|ASXC: Forward Price-to-Revenue Multiple|Forward Price to Sales AVGR (Avinger Inc.)|BioSig Technologies, Inc (BSGM) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple Cutera Inc|KNW (Know Labs, Inc.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio inarimedical.com NARI|Forward P/S Multiple NVRO|reshapelifesciences.com - Market Cap to Projected Revenue|Forward P/S Multiple SILK (Silk Road Medical Inc.)